Inverness, Dundee and Perth joined in 1975 and Newcastle in 1978 to form the present group, which has been supported by local charities, the Scottish Home and Health Department and the Cancer Research Campaign.
The aim of the Second National meeting of the Group was to provide a forum for exchanging information with other clinicians and pathologists in the U.K. The first meeting was held in 1978, but in future further national meetings will be held at 3 yearly intervals.
The symposium opened with a review of the potential of immunohistochemistry in aiding the diagnosis of non-Hodgkin's lymphomas on fresh and fixed material. K. Gatter (Oxford) reported that in adults, the usual problem is to distinguish lymphoma from anaplastic carcinoma where morphology alone can be not only unhelpful but even misleading. He placed particular emphasis on the progress which has been made in applying monoclonal antibodies to routinely fixed paraffin embedded tissues. There is at present no convincing evidence that EBV is the agent which causes the chromosomal (t8: 14) transformation that characterises the cells of EBVpositive and EBV-negative Burkitt's lymphoma. These data and those from immune-deprived patients in whom EBV infection may cause a polyclonal (sometimes eventually monoclonal) and fatal B cell lymphoproliferative condition, suggest that EBV constitutes at least one element in the multi-stage progression from normal function to malignancy of B lymphocytes.
G. Stockdill (Edinburgh) reported a case of adult T cell leukaemia-lymphoma in association with evidence of previous infection with a retrovirus that demonstrated strong positivity with a monoclonal antibody (P19) directed against the core protein of human T cell leukaemia virus (HTLV1). Gene probes failed to confirm this as being HTLV1 or HTLV2 but the possibility of this being a further variant is likely and emphasised the need for checking this aspect in patients with T cell malignancy.
J.C. Neil (Glasgow) reviewed the possible mechanisms involved in the oncogenic transformation of cell lines by reference to the ras oncogenes. He reiterated the possibility of a multiple gene activation by pointing to the observation that two or more oncogene mutations may occur in a given human tumour cell line providing further evidence that "natural" malignant transformation of B cells may be a multi-step process involving oncogene alterations.
The next section of the symposium focused on the sequelae of lymphoma and those attendant upon treatment of lymphoma. P.D.G. Davey (Dundee) has found a high incidence of subclinical thyroid dysfunction, judged by assessment of T3, T4, TRH and thyroid antibody levels in 18 patients with Hodgkin's disease treated by radiotherapy to the neck. By comparing the incidence with that seen in laryngeal carcinoma, similarly treated, he concluded that the high incidence in Hodgkin's disease might be the result of a combination of iodine load from lymphangiography followed by radiotherapy, or could be related to the disease itself or possibly to the lower age of the population, rendering them relatively more susceptible to these radiotherapy effects. Another series of Hodgkin's disease patients who had received no radiotherapy but who had had lymphangiography had a significantly lower incidence of detectable thyroid dysfunction.
N.B. Bennett (Aberdeen) reviewed the effect of chemotherapy and radiotherapy on fertility. Radiotherapy did not materially affect fertility, with 80% of young women so treated subsequently achieving pregnancy and the remaining 20% showing hormonal evidence *of normal ovarian function. Likewise, after radiotherapy 52% of young males had later fathered children or had normal spern counts. The remaining 48% of young men either refused to supply sperm for analysis or had declared that their family was already complete. All patients, of either sex, showed intact pituitary and gonadal function by endocrine analysis. However, chemotherapy strikingly impairs male fertility. Between 2 and 48 months following chemotherapy all men tested were azoospermic with elevated FSH levels but normal LH and testosterone levels. By contrast, 50% of women so treated were actually -or potentially fertile (20% pregnant, 30% normal endocrine function). Seventy-five per cent of women who had been on the contraceptive pill during chemotherapy retained evidence of fertility against only 43% fertile or potentially fertile of those who had not been on the contraceptive pill. The mean age of those still fertile post-treatment was 24 and for the infertile 31. Further analysis of these factors contributing to the retention of fertility is confounded by the considerable overlap of young age and oral contraceptive use. Thus whereas localised radiotherapy had no effect upon fertility, chemotherapy results in prolonged azoospermia in men whilst in women its influence depends on the woman's age whether or not she continues to take oral contraceptives during the cytotoxic chemotherapy.
J.E. Kingston (London) emphasised that patients with lymphoma, (especially those with Hodgkin's disease as the primary lymphoid malignancy) have a higher risk of second malignancy following treatment (-280 per 100,000 patients per annum post-Hodgkin's disease against a 131 per 100,000 patients per annum post-non-Hodgkin's lymphoma) (Mike, V., et al. (1982 ) Lancet, ii, 1326 -1330 . The U.K. Childhood Cancer Research Group data support these findings; in the period from 1962-1977 9/790 children with Hodgkin's disease later developed a second malignancy against 1/1,275 children who had had non-Hodgkin's lymphoma over the same period.
The psychological impact of lymphoma was discussed by Miss J. Devlen who studied patients in Manchester. Sixty-three per cent of patients interviewed had some degree of anxiety and/or depression much of it associated with the initial diagnosis and early treatment. However significant morbidity arises later in the disease with problems arising from the disruption to life due to hospital visits, conditioned nausea and vomiting due to treatment, memory impairment and physical symptoms.
The This report has concentrated on the formal presentations although there was a useful poster session and a well attended and enthusiastically received debating session which was devoted to the topic, "Staging: laparotomy has no part of play in the mangement of Hodgkin's disease" (for the motion A. Jeliffe, London against, A. Brewin, Glasgow). A second debate, "Chemotherapy has no role in the management of low grade nonHodgkin's lymphomas" (for the motion A. Lister, London, against the motion, J.G. MacVie, Amsterdam), was attended by a lively discussion.
